Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.33% | 1.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.33% | 1.67% | |||
| Cost of Revenue | -13.23% | -43.87% | |||
| Gross Profit | 19.07% | 36.56% | |||
| SG&A Expenses | -15.30% | -0.52% | |||
| Depreciation & Amortization | -0.82% | 20.58% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.10% | -16.91% | |||
| Operating Income | 101.74% | 640.72% | |||
| Income Before Tax | 239.43% | 166.12% | |||
| Income Tax Expenses | 169.47% | 88.11% | |||
| Earnings from Continuing Operations | 124.58% | -21.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 124.58% | -21.53% | |||
| EBIT | 101.74% | 640.72% | |||
| EBITDA | 58.24% | 157.09% | |||
| EPS Basic | 122.24% | -21.15% | |||
| Normalized Basic EPS | 214.43% | 201.23% | |||
| EPS Diluted | 120.00% | -23.08% | |||
| Normalized Diluted EPS | 213.93% | 198.97% | |||
| Average Basic Shares Outstanding | 1.00% | -0.43% | |||
| Average Diluted Shares Outstanding | 1.16% | 1.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||